The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent to Spanish active pharmaceutical ingredient (API) maker Interquim, S.A. for several good manufacturing practices ...
The roll-up in contract manufacturing continues. Italy’s P&R Group has added a Milan-based CMO to its active pharmaceutical ingredient business. P&R, which is also based in Milan, said last week that ...
The US Food and Drug Administration (FDA) has issued a warning letter to active pharmaceutical ingredient (API) maker Unimark Remedies Ltd. for poor manufacturing controls and data integrity issues at ...
American Capital ($ACAS), which already controls heparin maker Scientific Protein Laboratories, is expanding in the API industry. It will lay out $212 million to buy ...
Piramal Pharma Solutions (PPS), the contract development and manufacturing organisation of Piramal Pharma Ltd on Wednesday announced that it has entered into an agreement to acquire 100 per cent stake ...
An arm of the private equity firm TPG will invest $30 million in Solara Active Pharma, a maker of active pharmaceutical ingredients (APIs). Solara has five manufacturing sites and two research centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results